Aqneursa Side Effects
Generic name: levacetylleucine
Medically reviewed by Drugs.com. Last updated on Nov 10, 2024.
Note: This document provides detailed information about Aqneursa.
Applies to levacetylleucine: oral granules for oral suspension Side Effects associated with levacetylleucine. Some dosage forms listed on this page may not apply specifically to the brand name Aqneursa.
Applies to levacetylleucine: oral granules for oral suspension.
Side effects include:
Most common adverse reactions (≥5%): abdominal pain, dysphagia, upper respiratory tract infections, vomiting.
For healthcare professionals
Applies to levacetylleucine: oral granule for reconstitution.
General adverse events
Most common adverse reactions with a frequency of 5% or greater were abdominal pain, dysphagia, upper respiratory tract infections, and vomiting.[Ref]
Dermatologic
Gastrointestinal
- Common (1% to 10%): Abdominal pain, dysphagia, vomiting[Ref]
Hematologic
- Frequency not reported: Thrombocytopenia[Ref]
Respiratory
- Very common (10% or more): Upper respiratory tract infection (17%)[Ref]
See also:
References
1. (2024) "Product Information. Aqneursa (levacetylleucine)." IntraBio Inc
Frequently asked questions
More about Aqneursa (levacetylleucine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Aqneursa side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.
